PLAU and neoplasm: As Serp-1 inhibits both thrombolytic serine proteases tPA and uPA and also thrombotic proteases FX and FII, whereas NSP inhibits only tPA and uPA, we have posited that the majority of the anti-tumor activity is dependent upon the inhibition of the thrombolytic proteases tPA and uPA.